• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用超临界流体溶液增强分散法(SEDS)制备可生物降解的微粒。

Preparation of biodegradable microparticles using solution-enhanced dispersion by supercritical fluids (SEDS).

作者信息

Ghaderi R, Artursson P, Carlfors J

机构信息

Uppsala University, BMC, Department of Pharmaceutics, Sweden.

出版信息

Pharm Res. 1999 May;16(5):676-81. doi: 10.1023/a:1018868423309.

DOI:10.1023/a:1018868423309
PMID:10350010
Abstract

PURPOSE

We have evaluated a new process, involving solution-enhanced dispersion by supercritical fluids (SEDS), for the production of polymeric microparticles.

METHODS

The biodegradable polymers, Poly (DL-lactide-co-glycolide): copolymer composition 50:50 (DL-PLG), Poly (L-lactide) (L-PLA), Poly (DL-lactide) (DL-PLA) and Polycaprolactone (PCL), were used for preparation of microparticles using SEDS. Solutions of the polymers in organic solvents were dispersed and sprayed with supercritical CO2. Extraction of the organic solvents resulted in the formation of solid microparticles. The amounts of highly toxic solvents such as dichloromethane (MC) were reduced in the process.

RESULTS

Microparticles were obtained from all polymers. The mean particle size and shape varied with the polymer used. The morphology of the particles was strongly affected by the choice of polymer solvent. Discrete spherical microparticles of DL-PLG were produced with a mean volumetric diameter of 130 microm. The microparticles of the L-PLA were almost spherical, and their size increased from 0.5 to 5 microm as the density of supercritical CO2 decreased. PCL formed microparticles with diameters of 30-210 microm and showed a strong tendency to form films at high pressure.

CONCLUSIONS

The SEDS process appears a promising method for production of microparticles from biodegradable polymers without the use of toxic solvents.

摘要

目的

我们评估了一种新的工艺,即超临界流体增强溶液分散法(SEDS)用于制备聚合物微粒。

方法

使用可生物降解的聚合物聚(DL-丙交酯-共-乙交酯):共聚物组成50:50(DL-PLG)、聚(L-丙交酯)(L-PLA)、聚(DL-丙交酯)(DL-PLA)和聚己内酯(PCL),通过SEDS制备微粒。将聚合物在有机溶剂中的溶液分散并用超临界二氧化碳喷雾。有机溶剂的萃取导致形成固体微粒。该过程减少了二氯甲烷(MC)等高毒性溶剂的用量。

结果

从所有聚合物中均获得了微粒。平均粒径和形状随所用聚合物而变化。颗粒的形态受聚合物溶剂选择的强烈影响。制备出了平均体积直径为130微米的离散球形DL-PLG微粒。L-PLA微粒几乎呈球形,随着超临界二氧化碳密度的降低,其尺寸从0.5微米增加到5微米。PCL形成了直径为30 - 210微米的微粒,并且在高压下显示出强烈的成膜倾向。

结论

SEDS工艺似乎是一种无需使用有毒溶剂即可从可生物降解聚合物制备微粒的有前景的方法。

相似文献

1
Preparation of biodegradable microparticles using solution-enhanced dispersion by supercritical fluids (SEDS).使用超临界流体溶液增强分散法(SEDS)制备可生物降解的微粒。
Pharm Res. 1999 May;16(5):676-81. doi: 10.1023/a:1018868423309.
2
A new method for preparing biodegradable microparticles and entrapment of hydrocortisone in DL-PLG microparticles using supercritical fluids.一种制备可生物降解微粒以及使用超临界流体将氢化可的松包封于DL-聚乳酸-乙醇酸共聚物微粒中的新方法。
Eur J Pharm Sci. 2000 Mar;10(1):1-9. doi: 10.1016/s0928-0987(99)00079-2.
3
Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.使用超临界二氧化碳技术制备、表征负载吲哚美辛的聚乳酸/聚乳酸-羟基乙酸共聚物微粒及其体外细胞毒性
Eur J Pharm Biopharm. 2008 Sep;70(1):85-97. doi: 10.1016/j.ejpb.2008.03.011. Epub 2008 Mar 29.
4
Structured Biodegradable Polymeric Microparticles for Drug Delivery Produced Using Flow Focusing Glass Microfluidic Devices.采用流聚焦玻璃微流控器件制备用于药物输送的结构可生物降解聚合物微球。
ACS Appl Mater Interfaces. 2015 Oct 21;7(41):23132-43. doi: 10.1021/acsami.5b06943. Epub 2015 Oct 12.
5
Formation of bioerodible polymeric microspheres and microparticles by rapid expansion of supercritical solutions.通过超临界溶液快速膨胀制备可生物降解聚合物微球和微粒
Biotechnol Prog. 1991 Sep-Oct;7(5):403-11. doi: 10.1021/bp00011a004.
6
Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.微囊化方法和肽负载对聚乳酸和聚乳酸-乙醇酸共聚物体外测试期间降解的影响。
J Control Release. 1998 Feb 12;51(2-3):327-41. doi: 10.1016/s0168-3659(97)00188-0.
7
Encapsulation of lysozyme in a biodegradable polymer by precipitation with a vapor-over-liquid antisolvent.通过液上气相反溶剂沉淀法将溶菌酶包裹于可生物降解聚合物中。
J Pharm Sci. 1999 Jun;88(6):640-50. doi: 10.1021/js980237h.
8
Critical properties of lactide-co-glycolide polymers for the use in microparticle preparation by the aerosol solvent extraction system.用于通过气溶胶溶剂萃取系统制备微粒的丙交酯-乙交酯共聚物的关键性能
Int J Pharm. 1999 Aug 5;185(1):61-72. doi: 10.1016/s0378-5173(99)00127-1.
9
The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.基于丙交酯聚合物与聚乙二醇共混物的可生物降解微粒中胰岛素的稳定性
J Microencapsul. 2000 Nov-Dec;17(6):743-56. doi: 10.1080/02652040050161738.
10
Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states.生物可降解聚(D,L-丙交酯)和聚(D,L-丙交酯-共-乙交酯)薄膜在干燥和湿润状态下的物理机械性能
J Pharm Sci. 2000 Dec;89(12):1558-66. doi: 10.1002/1520-6017(200012)89:12<1558::aid-jps6>3.0.co;2-8.

引用本文的文献

1
Preparation and Characterization of Fenofibrate Microparticles with Surface-Active Additives: Application of a Supercritical Fluid-Assisted Spray-Drying Process.含表面活性添加剂的非诺贝特微粒的制备与表征:超临界流体辅助喷雾干燥工艺的应用
Pharmaceutics. 2021 Dec 2;13(12):2061. doi: 10.3390/pharmaceutics13122061.
2
PLA/PLGA-Based Drug Delivery Systems Produced with Supercritical CO-A Green Future for Particle Formulation?基于聚乳酸/聚乳酸-羟基乙酸共聚物的药物递送系统:超临界CO₂制备——颗粒制剂的绿色未来?
Pharmaceutics. 2020 Nov 20;12(11):1118. doi: 10.3390/pharmaceutics12111118.
3
Oral Bioavailability Enhancement and Anti-Fatigue Assessment of the Andrographolide Loaded Solid Dispersion.

本文引用的文献

1
Preparation of liposomes encapsulating water-soluble compounds using supercritical carbon dioxide.使用超临界二氧化碳制备包封水溶性化合物的脂质体。
J Pharm Sci. 1997 Aug;86(8):921-8. doi: 10.1021/js960403q.
2
Pharmaceutical processing with supercritical carbon dioxide.超临界二氧化碳的药物加工
J Pharm Sci. 1997 Aug;86(8):885-90. doi: 10.1021/js9700661.
3
Residual solvents in biodegradable microparticles. Influence of process parameters on the residual solvent in microparticles produced by the aerosol solvent extraction system (ASES) process.
载有穿心莲内酯的固体分散体的口服生物利用度增强和抗疲劳评估。
Int J Mol Sci. 2020 Apr 4;21(7):2506. doi: 10.3390/ijms21072506.
4
Solution-enhanced dispersion by supercritical fluids: an ecofriendly nanonization approach for processing biomaterials and pharmaceutical compounds.超临界流体增强的溶液分散法:一种用于加工生物材料和药物化合物的环保纳米化方法。
Int J Nanomedicine. 2018 Jul 23;13:4227-4245. doi: 10.2147/IJN.S166124. eCollection 2018.
5
Development of a Solid Dispersion System for Improving the Oral Bioavailability of Resveratrol in Rats.用于提高白藜芦醇在大鼠体内口服生物利用度的固体分散体系统的研发。
Eur J Drug Metab Pharmacokinet. 2017 Apr;42(2):239-249. doi: 10.1007/s13318-016-0339-0.
6
Development of core-shell microcapsules by a novel supercritical CO2 process.通过一种新型超临界二氧化碳工艺制备核壳微胶囊
J Mater Sci Mater Med. 2009 Mar;20(3):751-8. doi: 10.1007/s10856-008-3633-9. Epub 2008 Nov 6.
7
Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods.采用常规方法和超临界方法制备的葛根素磷脂复合物的比较理化特性
Pharm Res. 2008 Mar;25(3):563-77. doi: 10.1007/s11095-007-9418-x. Epub 2007 Sep 8.
8
Study of poly(L-lactide) microparticles based on supercritical CO2.基于超临界二氧化碳的聚(L-丙交酯)微粒的研究
J Mater Sci Mater Med. 2007 Dec;18(12):2339-45. doi: 10.1007/s10856-007-3173-8. Epub 2007 Jun 14.
9
Preparation of budesonide and budesonide-PLA microparticles using supercritical fluid precipitation technology.使用超临界流体沉淀技术制备布地奈德及布地奈德-聚乳酸微粒。
AAPS PharmSciTech. 2002;3(3):E18. doi: 10.1208/pt030318.
J Pharm Sci. 1997 Jan;86(1):101-5. doi: 10.1021/js960136o.
4
Production of drug loaded microparticles by the use of supercritical gases with the aerosol solvent extraction system (ASES) process.利用超临界气体和气溶胶溶剂萃取系统(ASES)工艺制备载药微粒。
J Microencapsul. 1996 Mar-Apr;13(2):131-9. doi: 10.3109/02652049609052902.
5
Polymeric microspheres prepared by spraying into compressed carbon dioxide.通过喷雾进入压缩二氧化碳制备的聚合物微球。
Pharm Res. 1995 Aug;12(8):1211-7. doi: 10.1023/a:1016276329672.